FIGURE 1.

A caregiver reported quality of life assessment instrument (CanBrainQOL) was used to assess well‐being of dogs whose intracranial masses were treated with radiotherapy and prednisone on a rapid‐taper schedule. Total CanBrainQOL scores for individual dogs are shown in this graph; data from dogs treated with conventionally fractionated definitive‐intent radiotherapy are shown as solid black squares, whereas data from dogs treated with either stereotactic radiotherapy (SRT) or radiosurgery (SRS) are shown as solid gray triangles. There were neither significant differences in total scores when comparing treatment approach (CFRT vs SRT/SRS) nor were there significant differences over time.